These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 11887986)

  • 21. Adjuvant hormonal treatment for prostate cancer: the bicalutamide early prostate cancer program.
    Wirth MP; Froehner M
    Oncology; 2003; 65 Suppl 1():1-4. PubMed ID: 12949426
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Case records of the Massachusetts General Hospital. Case 16-2011. A 67-year-old man with recurrent prostate cancer.
    Smith MR; Zietman AL; Finkelstein JS; Wu CL
    N Engl J Med; 2011 May; 364(21):2044-51. PubMed ID: 21612474
    [No Abstract]   [Full Text] [Related]  

  • 23. Role of radiation and androgen deprivation therapy for advanced prostate cancer.
    Jani AB; Rossi PJ
    Curr Probl Cancer; 2015; 39(1):41-7. PubMed ID: 25554467
    [No Abstract]   [Full Text] [Related]  

  • 24. Neoadjuvant hormonal treatment and radiotherapy for prostate cancer.
    Wachter S; Wachter-Gerstner N; Pötter R
    Oncology; 2003; 65 Suppl 1():29-33. PubMed ID: 12949431
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Is maximal androgenic blockade necessary in the treatment of prostatic cancer?].
    Matveev BP; Bukharkin BV
    Urologiia; 2003; (6):6-10. PubMed ID: 14708235
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Endocrine therapy for prostate cancer.
    Damber JE
    Acta Oncol; 2005; 44(6):605-9. PubMed ID: 16165920
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Medical therapy of prostate cancer. A review.
    Roscigno M; Sangalli M; Mazzoccoli B; Scattoni V; Da Pozzo L; Rigatti P
    Minerva Urol Nefrol; 2005 Jun; 57(2):71-84. PubMed ID: 15951731
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Hormonal therapy for advanced prostate cancer: current status and issues].
    Akakura K
    Nihon Rinsho; 2016 Jan; 74(1):124-8. PubMed ID: 26793892
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Secondary hormonal therapy for prostate cancer: what lies on the horizon?
    Sharifi N; Dahut WL; Figg WD
    BJU Int; 2008 Feb; 101(3):271-4. PubMed ID: 17922868
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Novel agents for metastatic hormone-sensitive prostate cancer - a practice guide for urologists.
    Thangasamy IA; Kwan EM; Teh J; Sathianathen N; Alghazo O; Siva S; Azad A; Murphy DG
    BJU Int; 2020 Mar; 125(3):342-345. PubMed ID: 31660679
    [No Abstract]   [Full Text] [Related]  

  • 31. Current evidence for the role of combined androgen suppression and radiation in the treatment of adenocarcinoma of the prostate.
    DeWeese TL; Song DY
    Urology; 2000 Feb; 55(2):169-74. PubMed ID: 10688072
    [No Abstract]   [Full Text] [Related]  

  • 32. [Early versus late hormonal treatment in advanced prostate cancer].
    Allepuz Losa C; Gil Martínez P; Gil Sanz MJ; Rioja Sanz LA
    Actas Urol Esp; 1999; 23(7):557-64. PubMed ID: 10488608
    [No Abstract]   [Full Text] [Related]  

  • 33. Secondary hormonal therapy for advanced prostate cancer.
    Lam JS; Leppert JT; Vemulapalli SN; Shvarts O; Belldegrun AS
    J Urol; 2006 Jan; 175(1):27-34. PubMed ID: 16406864
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Treatment options in androgen-independent prostate cancer.
    Lara PN; Meyers FJ
    Cancer Invest; 1999; 17(2):137-44. PubMed ID: 10071598
    [TBL] [Abstract][Full Text] [Related]  

  • 35. New treatment for advanced prostate cancer.
    FDA Consum; 2004; 38(2):4. PubMed ID: 15101352
    [No Abstract]   [Full Text] [Related]  

  • 36. New molecules and treatment modulation in advanced prostatic cancer.
    Mahler C; Verhelst J; Denis L
    Acta Urol Belg; 1996 May; 64(2):95-8. PubMed ID: 8701825
    [No Abstract]   [Full Text] [Related]  

  • 37. Monotherapy versus combined androgen blockade in patients with advanced prostate cancer.
    Errejon A; Crawford ED
    Cancer; 2002 Jul; 95(2):209-10. PubMed ID: 12124816
    [No Abstract]   [Full Text] [Related]  

  • 38. The benefits of early androgen blockade.
    Maroni PD; Crawford ED
    Best Pract Res Clin Endocrinol Metab; 2008 Apr; 22(2):317-29. PubMed ID: 18471789
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Carcinoma of the prostate: neoadjuvant hormonotherapy followed by radiotherapy.
    Scalliet P
    Acta Urol Belg; 1996 May; 64(2):63-4. PubMed ID: 8701815
    [No Abstract]   [Full Text] [Related]  

  • 40. New research reveals positive therapies and methods for treating prostate cancer.
    Mitka M
    JAMA; 2012 Aug; 308(5):441-2. PubMed ID: 22851092
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.